Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Medical Students’ Perceptions of Large Language Models in Healthcare: A Multinational Cross-Sectional Study
Ejas, Faiza, Khan, Sameer Asim , Mujahid, Amina, AlJoker, Fatma, Alvarado-Villa, Geovanny , Kashyap, Abhishek , Nigatu, Kindie Woubshet, Jain, Nethra , Iyer, Nandhini, Sandhu, Aman , Sharafat, Shahab, Yahya, Sara , Ghaly, Mohamd Mahmoud, Ibrar, Ibrahim Hassan , Grewal, Harpreet , Mehta, Priyal , Arshad, Zara , Yahya, Sara , Ghaly, Mohamd Mahmoud , Singh, Aakanksha , Grewal, Harpeet , Arshad, Zara , Khan, Sameer Asim , Mujahid, Amina, Mautong, Hans , Kashyap, Abhishek, Yasir, Muhammad Umer , Iyer, Nandhini , Huespe, Iván , Kashyap, Rahul , Nawaz, Faisal A.

Journal of Medical Education and Curricular Development | May 21, 2025 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/23821205251331124 | PMID 40672122 Get It

Background Artificial intelligence (AI) and large language models (LLMs), are potential tools for enhancing healthcare delivery and clinical research. Presently, there is a scarcity of research regarding the viewpoints of medical students toward LLMs. This study aims to explore the perceptions of LLMs and their applications among this demographic. Methods A cross-sectional study was done using an online survey. It was designed using Google Forms and circulated from July 2023 to August 2023. The target population included medical students from Ecuador, Ethiopia, India, Mauritius, Pakistan, United Arab Emirates (UAE), and the United States (USA). Results A total of 1180 responses were collected from 10 medical colleges across 7 countries. The UAE had the largest number of responses (31.7%), followed by Ecuador (17.6%), and Mauritius (13.7%). And 77.4% respondents were already aware about LLMs before attempting the survey, most popularly, ChatGPT. Participants were most familiar with the specific use of LLMs in research (46%), and the lowest familiarity was seen in the use of LLMs in healthcare (37%). More than half of the participants (52%) support the use of LLMs healthcare, yet a significant number of them remained neutral (37%) or disagreed (31%) on LLMs being safe in this context. Conclusion While most of the medical students are aware of LLMs and their applications, the multinational survey demonstrated hesitancy among medical students in fully adopting LLMs into healthcare practice and clinical research. This study prompts further exploration of medical students’ attitudes and acceptance concerning the integration of LLMs for research methodologies, ethical considerations, and healthcare practice.
Efficacy and safety of transradial versus transfemoral access for mechanical thrombectomy in acute ischemic stroke: A systematic review and meta-analysis
Rehman, Muhammad Aemaz Ur , Rehman, Muhammad Ebaad Ur , Ali, Hamza , Rehman, Muhammad , Ghozy, Sherief , Tariq, Muhammad Bilal , Kallmes, David F. , Aemaz Ur Rehman, Muhammad , Rehman, Mohammad Ammar Ur , Ghozy, Sherief , Kallmes, David F

Interventional Neuroradiology | May 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15910199251342049 | PMID 40398466 Get It

Background Mechanical thrombectomy for ischemic stroke has traditionally been performed via transfemoral access (TFA). However, newer literature on the subject suggests that transradial access (TRA) may be equally efficacious. Methods Online databases (including PubMed, Google Scholar, Embase, and Cochrane) were queried from inception until May 2024. Abstracts and full texts were screened according to Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. Risk of bias assessment was performed using standardized screening tools. All dichotomous outcomes were reported as odds ratio (OR) with 95% confidence interval (CI). RevMan was used to perform the statistical analysis. Results Thirteen observational studies and one randomized clinical trial (RCT) were included in this meta-analysis. The total sample size was 4973, 4074 patients (81.2%) were in the TFA group, and 899 (18.8%) were in the TRA group. No significant differences were observed between the two groups in terms of successful recanalization (OR = 0.92; 95% CI 0.66–1.27; p = 0.60), first-pass recanalization (OR = 0.84; 95% CI 0.69–1.01, p = 0.06), access to reperfusion time (mean difference −2.99 min; 95% CI −8.33 to 2.44, p = 0.27), and favorable functional outcome. Mortality and rates of intracranial hemorrhage were comparable between the two groups, but access site complications were significantly lower in the TRA group (OR = 0.57; 95% CI 0.37–0.88; p = 0.01). Conclusion TRA for thrombectomy in large vessel ischemic strokes is comparable to TFA in terms of efficacy and has a lower incidence of access site complications. RCT data comparison of the two techniques is limited, underscoring the importance of conducting trials.
A multicenter, propensity score-matched analysis of functional outcomes and recanalization success with or without Trevo for Medium and distal vessel occlusion
Siegler, James E. , Koneru, Manisha , Shaikh, Hamza, Salim, Hamza , Musmar, Basel , Adeeb, Nimer , Yedavalli, Vivek , Tjoumakaris, Stavropoula , Henninger, Nils , Sundararajan, Sri Hari , Tan, Benjamin Yong‐Qiang , Heit, Jeremy J , Regenhardt, Robert W. , Kass‐Hout, Tareq , Fiehler, Jens, Puri, Ajit S , Dyzmann, Christian , Barreau, Xavier, Renieri, Leonardo, Filipe, João Pedro , Harker, Pablo, Marotta, Thomas R. , Spears, Julian , Biswas, Arundhati , Clarençon, Frédéric, Abdalkader, Mohamad , Varela, Ricardo , Baker, Amanda , Altschul, David , Gonzalez, Nestor R. , Möhlenbruch, Markus A, Costalat, Vincent, Gory, Benjamin, Stracke, Christian Paul , Hecker, Constantin, Liebeskind, David S. , Alexandre, Andrea , Tancredi, Illario , Faizy, Tobias D. , Kalsoum, Erwah , Lubicz, Boris , Patel, Aman B. , Khalife, Jane, Rana, Ankit, Guenego, Adrien , Investigators, for the MAD MT, Heit, Jeremy J. , Salim, Hamza , Tjoumakaris, Stavropoula , Henninger, Nils , Kühn, Anna Luisa , Ghozy, Sherief , Scarcia, Luca , Regenhardt, Robert W , Morsi, Rami Z , Vigilante, Nicholas , Rouchaud, Aymeric , Essibayi, Muhammed Amir , Dyzmann, Christian , Colasurdo, Marco , Filipe, João Pedro , Alexandru Radu, Răzvan , Ota, Takahiro , Jabbour, Pascal , Klein, Piers , Nguyen, Thanh N , Altschul, David J , Gonzalez, Nestor R , Griessenauer, Christoph J , Liebeskind, David S. , Tancredi, Illario , Guenego, Adrien , Dmytriw, Adam A , Heit, Jeremy J , Musmar, Basel , Yedavalli, Vivek S , Siegler, James E , Tan, Benjamin Yq , Alexandre, Andrea M , Varela, Ricardo , Daraghma, Motaz , Kühn, Anna Luisa , Ghozy, Sherief , Morsi, Rami Z. , Cancelliere, Nicole M , Bernstock, Joshua D. , Rouchaud, Aymeric , Sheth, Sunil A , Essibayi, Muhammed Amir , Colasurdo, Marco , Barreau, Xavier , Renieri, Leonardo , Harker, Pablo , Radu, Răzvan Alexandru , Mowla, Ashkan , Jabbour, Pascal , Clarençon, Frédéric , Klein, Piers , Nguyen, Thanh N. , Möhlenbruch, Markus , Costalat, Vincent , Gory, Benjamin , Hecker, Constantin , Griessenauer, Christoph J. , Pedicelli, Alessandro , Mendes Pereira, Vitor , Khalife, Jane , Dmytriw, Adam A. , Investigators, for the MAD MT

Interventional Neuroradiology | May 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15910199251341603 | PMID 40398470 Get It

Background Endovascular therapy (EVT) for stroke due to distal or medium vessel occlusion (DMVO) is safe. Due to the distinct anatomical characteristics of DMVOs, further evaluation of EVT is crucial to determine which devices may yield better outcomes. Methods A retrospective analysis of adults with DMVO treated in 37 centers (11 countries) was queried. The primary outcome of favorable shift in 90-day modified Rankin Scale (mRS) was compared between patients treated with Trevo versus other devices on first pass using 1:1 propensity score matching (PSM) with multivariable adjustment. Secondary outcomes included the number of pass attempts, final thrombolysis in cerebral infarction (TICI) score 2b-3, symptomatic intracranial hemorrhage (sICH), improvement in National Institutes of Health Stroke Scale (NIHSS) at 24h, and 90-day mortality. Results Of the 1115 included patients, 264 (24%) were treated with Trevo (PSM cohort of 261 per group). Trevo use was not associated with a favorable 90-day mRS shift (proportional odds ratio [OR] 1.10, 95% confidence interval [CI] 0.80–1.51). Trevo was associated with fewer passes (adjusted β=-0.25, 95% CI −0.48 - −0.03), higher odds of TICI 2b-3 (adjusted OR 1.97, 95% CI 1.11–3.49), and a greater 24h NIHSS improvement (adjusted β= −1.74, 95% CI −3.11 - −0.36), with no difference in sICH or mortality (p>0.05). Results were similar in sensitivity analyses. Conclusions We observed no safety concerns with Trevo as compared to other EVT devices for DMVO recanalization. There was a signal of better technical efficacy and early clinical improvement.
Burnout in Japanese Internists and Primary Care Physicians in 2024: The Prevalence and Risk Factors Using Structural Equation Modeling
Kuriyama, Akira , Nonaka, Saori , Ishizuka, Kosuke , Fukuzawa, Fumitoshi , Shimura, Hanae, Yamamoto, Noriko, Moriya, Mitsuru, Group, on behalf of Japan Physicians Well-being 2024 Study, Shikino, Kiyoshi , Nishimura, Yoshito , Sadohara, Michito , Shimura, Hanae, Yamamoto, Noriko, Group, on behalf of Japan Physicians Well-being 2024 Study

Internal Medicine | May 21, 2025 | Volume: 64 | Issue: 23 | Pages: 3349-3353

10.2169/internalmedicine.5530-25 | PMID 40399092 Get It

Immunotherapy for atherosclerosis
McNamara, Coleen A. , Slütter, Bram , Bekiranov, Stefan , Gonçalves, Isabel , Lutgens, Esther , Monaco, Claudia , Foks, Amanda C , Lutgens, Esther , Monaco, Claudia , Mulder, Willem J. M.

Physiological Reviews | May 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1152/physrev.00016.2024 | PMID 40397615 Get It

Cardiovascular disease is the global #1 cause of mortality and morbidity. The majority of cardiovascular diseases is caused by atherosclerosis, a lipid-driven, inflammatory disease of the middle- and large-sized arteries. The disease is characterized by the formation of atherosclerotic plaques throughout the arterial tree. Over the years, insights into the pathogenesis of atherosclerosis have shifted from a ‘lipid-driven’ model to a ‘response-to-injury’ perspective, and more recently to a ‘lipid-driven inflammatory disease’ viewpoint. We are now aware that a network of multiple immune cell-types and -subsets of the innate and adaptive immune system inhabit our arteries. Intricate interactions between these immune cellsubsets, non-immune cells, and local environmental substances such as lipids, cell debris and calcium cause a fluidic balance of pro-inflammatory and regulatory responses. A dysregulation of this balance towards a pro-inflammatory milieu drives atherosclerotic disease progression. Although we have acknowledged that atherosclerosis is an inflammatory disease, state-of-theart treatments are still based on lipid lowering, anti-hypertensive and lifestyle-changing strategies. In the past decade, clinical phase I, II and III trials targeting the immune system revealed that patients tolerate immunotherapy, show decreased inflammation and/or had a reduction in cardiovascular endpoints. However, the search for novel immunotherapeutic targets and treatment regimens as well as stratification of patients who would benefit from such treatments to combat atherosclerotic cardiovascular disease is only just beginning. In this review article, we will highlight the newest insights on the different cell subsets and components of the immune system in atherosclerosis and elaborate on current and future immunotherapeutics to treat atherosclerotic cardiovascular disease.
Coronary Artery Displacement and Narrowing on CT in the Setting of Giant Sinus of Valsalva Aneurysms
Yoon, Garrett, Dutta, Arka, Viggiano, Joseph T. , Maldjian, Pierre D., Dutta, Arka

Roentgen Ray Review | May 21, 2025 | Volume: 1 | Issue: 2 | Pages: No page available

10.2214/r3j.25.01007 Get It

Impella 5.5 as Heart Transplant Bridge Facilitated Rehabilitation and Improves Post-Transplant Outcomes: Retrospective Cohort Study
Jonna, Sadhana , Olaizola, Gustavo , Raavi, Lekhya , Bauque, Susana, Jena, Anek , Pareek, Aayushi , Bateh, Said , Hanson, Abby , Haney, John C. , Amoroso, Penny, Vilela, Sara , BRITTON, KIMBERLY, Matos, Nikki , Ojard, Michelle, Kiley, Sean , Hannon, Rachel, Leoni, Juan , Lyle, Melissa , Thomas, Mathew , Sareyyüpoğlu, Başar , Sura, Lydia, Davis, Olivia , Worsowicz, Greg, Patel, Parag C. , Sanghavi, Devang , Isha, Shahin , Leoni Moreno, Juan Carlos, Worsowicz, Greg M, Sanghavi, Devang K., Thomas, Mathew , Huespe, Iván , Perez, Allison, Leoni, Juan Carlos , Pham, Si M. , Franco, Pablo Moreno

ASAIO Journal | May 21, 2025 | Volume: 72 | Issue: 1 | Pages: 49-55

10.1097/mat.0000000000002460 | PMID 40397685 Get It

Heart transplantation is a well-established treatment for end-stage heart failure, but many patients present in poor physical condition, complicating outcomes. The Impella 5.5 device, used in cardiogenic shock, may support pretransplant rehabilitation by stabilizing organ function and promoting functional improvement. This retrospective cohort study assessed the relationship between functional status, measured by standardized Activity Measure for Post-Acute Care Basic Mobility (AM-PAC) scores, and days alive outside the hospital within 30 days post-transplant (DAOH-30). Patients who received Impella 5.5 support before transplantation between January 2019 and October 2023 were included, excluding those without AM-PAC scores within 24 hours pretransplant. Among 65 patients, the median DAOH-30 was 15 days (interquartile range [IQR], 8–19). Higher pretransplant standardized AM-PAC scores correlate with increased DAOH-30 (adjusted coefficient 0.3; 95% confidence interval [CI] = 0.01–0.6; p = 0.04), as did AM-PAC score improvement during rehabilitation (adjusted coefficient 0.35; 95% CI = 0.01–0.6; p = 0.04). Extended rehabilitation was associated with greater functional gains. These findings suggest that better pretransplant functional status and rehabilitation-related improvements were associated with increased DAOH-30. The Impella 5.5 device facilitates rehabilitation and may enhance post-transplant outcomes. Further research should refine strategies to optimize rehabilitation and recovery in this high-risk population.
Impact of Marine Microplastics on Neurologic and Functional Disabilities: A Population‐Level Study
Makwana, Bhargav , Desai, Brinda, Srinivasan, Jayashri, Apetauerova, Diana, Sehgal, Siddharth, Yerstein, Oleg , Nasir, Khurram , Kong, Yixin , Rajagopalan, Sanjay , Al‐Kindi, Sadeer , Ganatra, Sarju , Ganatra, Sarju , Desai, Brinda, Dani, Sourbha S. , Khadke, Sumanth , Kumar, Ashish , Wadhera, Rishi K. , Navas‐Acién, Ana , Adamkiewicz, Gary , Moffatt‐Bruce, Susan D.

European Journal of Neurology | May 21, 2025 | Volume: 32 | Issue: 5 | Pages: No page available

10.1111/ene.70144 | PMID 40396917 Get It

ABSTRACTBackgroundMicroplastics are emerging as environmental pollutants with potential neurotoxic effects, yet their association with neurological disabilities remains largely unexplored.MethodsIn this cross‐sectional study comprising 218 coastal counties in the United States, we compared the self‐reported prevalence of cognitive disability, mobility disability, self‐care disability, and independent living disability in counties with very high and low marine microplastic levels (MMLs). Unadjusted and adjusted prevalence ratios (PRs) were computed using population‐weighted quasi‐Poisson regression across three different models to examine the relationship between disability prevalence and MMLs.ResultsCounties exposed to very high marine microplastic levels had a higher mean prevalence of self‐reported cognitive disability (15.2% vs. 13.9%), mobility disability (14.1% vs. 12.3%), self‐care disability (4.2% vs. 3.6%), and independent living disability (8.5% vs. 7.7%) compared to those exposed to low levels (p < 0.001). Regression analyses revealed significantly elevated adjusted prevalence ratios (PRs) for cognitive (PR: 1.09 [95% CI: 1.06–1.12], p < 0.001), mobility (PR: 1.06 [1.03–1.10], p < 0.001), self‐care (PR: 1.16 [1.11–1.20], p < 0.001), and independent living disability (PR: 1.08 [1.05–1.12], p < 0.001) in counties with very high microplastic exposure compared to those with low exposure.ConclusionsThis study highlights a significant association between marine microplastic pollution and the self‐reported prevalence of cognitive, mobility, self‐care, and independent living disabilities at the county level. While merely associative, these findings emphasize the urgent need for further investigation into the individual‐level health impacts of microplastic exposure and underscore the importance of environmental interventions to mitigate potential risks.
Lines on the line: evaluating the impact of antibiotic lock therapy versus catheter removal in the management of central vascular catheter infections
Ranganath, Nischal , Nair, Vaisak , Dumais, Mitchell , Stevens, Ryan W. , Kind, Dalton R., Shah, Aditya , Tabaja, Hussam , Nair, Vaisak O , Stevens, Ryan W , Kind, Dalton, O'horo, John, Shah, Aditya S , Ranganath, Nischal , Dumais, Mitchell G , LeMahieu, Allison , O’Horo, John C.

Journal of Antimicrobial Chemotherapy | May 21, 2025 | Volume: 80 | Issue: 7 | Pages: 2016-2024

10.1093/jac/dkaf168 | PMID 40470775 Get It

Abstract Objectives To compare the efficacy and safety of antibiotic lock therapy (ALT) versus catheter removal in managing central vascular catheter–associated bloodstream infection (CVC-BSI). Methods We conducted a single-centre, retrospective cohort study of adult patients treated with ALT or catheter removal for management of CVC-BSI between 2018 and 2022. The primary outcome was a composite of 90 day microbiological relapse or recurrent BSI. Secondary outcomes included 30 day mortality, CVC-associated complications and Clostridioides difficile infection (CDI). Logistic regression with propensity score-adjustment was used to evaluate differences in outcomes and identify predictors of relapse. Results During the study period, 106 participants received ALT and 181 underwent catheter removal. Patients treated with ALT received shorter courses of systemic antimicrobials (11 versus 14 days; P &lt; 0.001) and had shorter hospital stays (4 versus 10 days; P &lt; 0.001). Median duration of catheter salvage in patients receiving ALT was 28 days (IQR 7–80). Primary composite outcome was similar between both groups, but ALT was associated with a significantly higher risk of microbiological relapse within 90 days (20% versus 7%; adjusted odds ratio 3.93, 95% CI 1.64–9.40; P = 0.002). No significant difference in 30 day mortality, CVC-related complications or CDI was observed. CoNS BSI was an independent predictor of microbiological relapse in patients treated with ALT (OR 2.28; P = 0.05). Conclusions Although ALT offers a non-invasive catheter salvage strategy, its association with higher relapse rates, particularly in CoNS BSI, suggests catheter removal should remain the preferred approach when feasible. ALT could be considered a short-term catheter salvage strategy for pathogens with low virulence when used with close surveillance.
Practical Guidance for Clinical Microbiology Laboratories: Antibody and antigen detection methods for dimorphic fungal infections
Theel, Elitza S. , Kus, Julianne V. , Grys, Thomas E. , Ampel, Neil M. , Schwartz, Ilan S. , Zhang, Sean X. , Zhang, Sean X , Kus, Julianne V , Grys, Thomas E

Clinical Microbiology Reviews | May 21, 2025 | Volume: 38 | Issue: 2 | Pages: No page available

10.1128/cmr.00005-20 | PMID 40396718 Get It

SUMMARY Antibody and antigen detection assays continue to play a significant role in the diagnosis of dimorphic fungal pathogens, including Blastomyces dermatitidis complex, Coccidioides immitis/posadasii , Paracoccidioides species, Histoplasma species , Sporothrix species, and Talaromyces marneffei . The performance characteristics of serologic and antigen detection assays for these pathogens are variable, however, influenced by multiple factors, including sample type, disease presentation, patient immunostatus, and timing of specimen collection relative to symptom onset. As a result, there is a need for a centralized document summarizing the accuracy of currently available antibody and antigen detection assays for each of these agents, including discussion of individual assay nuances and caveats that should be considered by clinicians and laboratorians alike. In addition, this review provides expert recommendations for the utilization and interpretation of serologic and antigen detection assays for these dimorphic pathogens.